{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T11:51:41Z","timestamp":1720180301774},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"15-16","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s00508-010-1421-2","type":"journal-article","created":{"date-parts":[[2010,8,3]],"date-time":"2010-08-03T11:05:43Z","timestamp":1280833543000},"page":"479-485","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Umfrage zur Arzneimitteldosierung bei Niereninsuffizienz unter nephrologisch t\u00e4tigen \u00c4rzten"],"prefix":"10.1007","volume":"122","author":[{"given":"Sebastian","family":"Maus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caecilia","family":"Holch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Czock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Thalhammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frieder","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertram","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,4]]},"reference":[{"key":"1421_CR1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.5414\/CPP41451","volume":"41","author":"JH Proost","year":"2003","unstructured":"Proost JH, Punt NC (2003) Dose individualization in PharmDIS-e+. Int J Clin Pharmacol Ther 41: 451\u20138","journal-title":"Int J Clin Pharmacol Ther"},{"key":"1421_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0169-2607(97)00061-8","volume":"55","author":"F Keller","year":"1998","unstructured":"Keller F, Frankewitsch T, Zellner D, Simon S, Czock D, Giehl M (1998) Standardized structure and modular design of a pharmacokinetic database. Comput Methods Programs Biomed 55: 107\u201315","journal-title":"Comput Methods Programs Biomed"},{"key":"1421_CR3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1055\/s-0038-1634673","volume":"35","author":"D Zellner","year":"1996","unstructured":"Zellner D, Schromm T, Frankewitsch T, Giehl M, Keller F (1996) Structured data entry for reliable acquisition of pharmacokinetic data. Methods Inf Med 35: 261\u20134","journal-title":"Methods Inf Med"},{"key":"1421_CR4","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00228-004-0852-y","volume":"60","author":"M Martin-Facklam","year":"2005","unstructured":"Martin-Facklam M, Rengelshausen J, Tayrouz Y, Ketabi-Kiyanvash N, Lindenmaier H, Schneider V, Bergk V, Haefeli WE (2005) Dose individualisation in patients with renal insufficiency: does drug labelling support optimal management? Eur J Clin Pharmacol 60: 807\u201311","journal-title":"Eur J Clin Pharmacol"},{"key":"1421_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.amjopharm.2008.07.002","volume":"6","author":"WJ Spruill","year":"2008","unstructured":"Spruill WJ, Wade WE, Cobb HH 3rd (2008) Comparison of estimated glomerular filtration rate with estimated creatinine clearance in the dosing of drugs requiring adjustments in elderly patients with declining renal function. Am J Geriatr Pharmacother 6: 153\u201360","journal-title":"Am J Geriatr Pharmacother"},{"key":"1421_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.2165\/00003088-197601020-00004","volume":"1","author":"L Dettli","year":"1976","unstructured":"Dettli L (1976) Drug dosage in renal disease. Clin Pharmacokinet 1: 126\u201334","journal-title":"Clin Pharmacokinet"},{"key":"1421_CR7","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.2215\/CJN.01840506","volume":"1","author":"D Czock","year":"2006","unstructured":"Czock D, H\u00fcsig-Linde C, Langhoff A, Sch\u00f6pke T, Hafer C, de Groot K, Swoboda S, Kuse E, Haller H, Fliser D, Keller F, Kielstein JT (2006) Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis. Clin J Am Soc Nephrol 1: 1263\u20138","journal-title":"Clin J Am Soc Nephrol"},{"key":"1421_CR8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1517\/17425250902913808","volume":"5","author":"D Czock","year":"2009","unstructured":"Czock D, Markert C, Hartman B, Keller F (2009) Pharmacokinetics and pharmacodynamics of antimicrobial drugs. Exp Opin Drug Metab Toxicol 5: 475\u201387","journal-title":"Exp Opin Drug Metab Toxicol"},{"key":"1421_CR9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.7326\/0003-4819-67-1-151","volume":"67","author":"CM Kunin","year":"1967","unstructured":"Kunin CM (1967) A guide to use of antibiotics in patients with renal disease. A table of recommended doses and factors governing serum levels. Ann Intern Med 67: 151\u20138","journal-title":"Ann Intern Med"},{"key":"1421_CR10","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1128\/AAC.01468-07","volume":"52","author":"VH Tam","year":"2008","unstructured":"Tam VH, Ledesma KR, Vo G, Kabbara S, Lim TP, Nikolaou M (2008) Pharmacodynamic modeling of aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: identifying dosing regimens to suppress resistance development. Antimicrob Agents Chemother 52: 3987\u201393","journal-title":"Antimicrob Agents Chemother"},{"key":"1421_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/00007691-198706000-00004","volume":"9","author":"F Keller","year":"1987","unstructured":"Keller F, Borner K, Schwarz A, Offermann G, Lode H (1987) Therapeutic aminoglycoside monitoring in renal failure patients. Ther Drug Monit 9: 148\u201353","journal-title":"Ther Drug Monit"},{"key":"1421_CR12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1365-2125.2004.02143.x","volume":"58","author":"ME DelDot","year":"2004","unstructured":"DelDot ME, Lipman J, Tett SE (2004) Vancomycin pharmacokinetics in critically illpatients receiving continuous venovenous haemodiafiltration. Br J Clin Pharmacol 58: 259\u201368","journal-title":"Br J Clin Pharmacol"},{"key":"1421_CR13","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/clinids\/24.5.786","volume":"24","author":"TC Bailey","year":"1997","unstructured":"Bailey TC, Little JR, Littenberg B, Reichley RM, Dunagan WC (1997) A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis 24: 786\u201395","journal-title":"Clin Infect Dis"},{"key":"1421_CR14","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/bmj.312.7027.338","volume":"312","author":"M Barza","year":"1996","unstructured":"Barza M, Ioannidis JP, Cappelleri JC, Lau J (1996) Single or multiple daily doses of aminoglycosides: a meta-analysis. BMJ 312: 338\u201345","journal-title":"BMJ"},{"key":"1421_CR15","doi-asserted-by":"publisher","first-page":"997","DOI":"10.2165\/00003088-200746120-00003","volume":"46","author":"F Pea","year":"2007","unstructured":"Pea F, Viale P, Pavan F, Furlanut M (2007) Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy. Clin Pharmacokinet 46: 997\u20131038","journal-title":"Clin Pharmacokinet"},{"key":"1421_CR16","first-page":"140","volume":"10","author":"B Meyer","year":"2005","unstructured":"Meyer B, Guttmann C, Dittrich E, Schmaldienst S, Thalhammer F (2005) Intermittent administration of betalactam-antibiotics for treatment of severe infection in hemodialysis patients. Eur J Med Res 10: 140\u20134","journal-title":"Eur J Med Res"},{"key":"1421_CR17","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1093\/ndt\/gfn343","volume":"23","author":"R Zvonar","year":"2008","unstructured":"Zvonar R, Natarajan S, Edwards C, Roth V (2008) Assessment of vancomycin use in chronic haemodialysis patients: room for improvement. Nephrol Dial Transplant 23: 3690\u20135","journal-title":"Nephrol Dial Transplant"},{"key":"1421_CR18","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/jac\/48.6.881","volume":"48","author":"M Valtonen","year":"2001","unstructured":"Valtonen M, Tiula E, Takkunen O, Backman JT, Neuvonen PJ (2001) Elimination of the piperacillin\/tazobactam combination during continuous venovenous haemofiltration and haemodiafiltration in patients with acute renal failure. J Antimicrob Chemother 48: 881\u20135","journal-title":"J Antimicrob Chemother"},{"key":"1421_CR19","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s001340050424","volume":"23","author":"TS van der Werf","year":"1997","unstructured":"van der Werf TS, Mulder PO, Zijlstra JG, Uges DR, Stegeman CA (1997) Pharmacokinetics of piperacillin and tazobactam in critically ill patients with renal failure, treated with continuous veno-venous hemofiltration (CVVH). Intensive Care Med 23: 873\u20137","journal-title":"Intensive Care Med"},{"key":"1421_CR20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2165\/00003088-200645050-00004","volume":"45","author":"N Simon","year":"2006","unstructured":"Simon N, Dussol B, Sampol E, Purgus R, Brunet P, Lacarelle B, Berland Y, Bruguerolle B, Urien S (2006) Population pharmacokinetics of ceftriaxone and pharmacodynamic considerations in haemodialysed patients. Clin Pharmacokinet 45: 493\u2013501","journal-title":"Clin Pharmacokinet"},{"key":"1421_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1046\/j.1563-2571.2002.02017.x","volume":"29","author":"R Bellmann","year":"2002","unstructured":"Bellmann R, Egger P, Gritsch W, Bellmann-Weiler R, Joannidis M, Dunzendorfer S, Wiedermann ChJ (2002) Pharmacokinetics of ciprofloxacin in patients with acute renal failure undergoing continuous venovenous haemofiltration: influence of concomitant liver cirrhosis. Acta Med Austriaca 29: 112\u20136","journal-title":"Acta Med Austriaca"},{"key":"1421_CR22","unstructured":"Weiterbildungsordnung Teilgebiet Nephrologie (1997) \u00c4rzteblatt Baden W\u00fcrttemberg. 11: 37"},{"key":"1421_CR23","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604\u201312","journal-title":"Ann Intern Med"},{"key":"1421_CR24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5414\/IBP33169","volume":"33","author":"D Czock","year":"2008","unstructured":"Czock D, Keller F, Paar WD, Thalhammer F (2008) Nierenersatztherapie beim kritisch Kranken. Soll man Antibiotika bei kontinuierlicher H\u00e4mofiltration anders dosieren? Intensiv- und Notfallbehandlung 33: 169\u201383","journal-title":"Intensiv- und Notfallbehandlung"},{"key":"1421_CR25","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s00134-003-1715-1","volume":"29","author":"A Sandiumenge","year":"2003","unstructured":"Sandiumenge A, Diaz E, Bod\u00ed M, Rello J (2003) Therapy of ventilator-associated pneumonia. A patient-based approach based on the ten rules of \"The Tarragona Strategy\". Intensive Care Med 29: 876\u201383","journal-title":"Intensive Care Med"},{"key":"1421_CR26","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1592\/phco.29.5.593","volume":"29","author":"RH Drew","year":"2009","unstructured":"Drew RH, White R, MacDougall C, Hermsen ED, Owens RC Jr (2009) Society of Infectious Diseases Pharmacists. Insights from the Society of Infectious Diseases Pharmacists on antimicrobial stewardship guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Pharmacotherapy 29: 593\u2013607","journal-title":"Pharmacotherapy"},{"key":"1421_CR27","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/B978-3-437-23900-7.50022-5","volume-title":"Facharzt Nephrologie","author":"F Keller","year":"2008","unstructured":"Keller F (2008) Nephrotoxische St\u00f6rungen und nierenabh\u00e4ngige Arzneimittel. In: Risler T, K\u00fchn K (eds) Facharzt Nephrologie. Urban & Fischer, M\u00fcnchen, pp 891\u2013956"},{"key":"1421_CR28","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/j.1525-1438.2007.00847.x","volume":"17","author":"YF Li","year":"2007","unstructured":"Li YF, Fu S, Hu W, Liu JH, Finkel KW, Gershenson DM, Kavanagh JJ (2007) Systemic anticancer therapy in gynecological cancer patients with renal dysfunction. Int J Gynecol Cancer 17: 739\u201363","journal-title":"Int J Gynecol Cancer"},{"key":"1421_CR29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2165\/00003088-198106030-00002","volume":"6","author":"P Chennavasin","year":"1981","unstructured":"Chennavasin P, Brater DC (1981) Nomograms for drug use in renal disease. Clin Pharmacokinet 6: 193\u2013214","journal-title":"Clin Pharmacokinet"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-010-1421-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-010-1421-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-010-1421-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-010-1421-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T13:13:16Z","timestamp":1589893996000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-010-1421-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":29,"journal-issue":{"issue":"15-16","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["1421"],"URL":"https:\/\/doi.org\/10.1007\/s00508-010-1421-2","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"21 January 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}